Velikij, rahuldame nõudlust : )<br /><br />Straight-Up Action Could Trap the Bears Again<br />By Rev Shark<br />RealMoney.com Contributor<br />11/9/2009 7:57 AM EST <br /><br />Rules are mostly made to be broken and are too often for the lazy to hide behind. <br />-- General Douglas MacArthur<br /><br />With a strong open this morning, the major indices are looking for their sixth straight day of gains. This follows some ugly technical action at the end of October that had many thinking that a long-awaited correction was finally at hand. <br /><br />This straight-up bounce on mediocre volume is technically questionable, but this market has consistently produced this sort of action. We had identical straight-up bounces at the beginning of July, September and October, and in each case we just kept running until we made new highs. <br /><br />The tricky part about this action is that technical analysis tells us that stocks usually don't recover so quickly and easily after the sort of selling that we have seen since we topped out a couple weeks ago. You expect buyers to be a bit more hesitant and for there to be at least some momentary hesitation to cut through technical overhead. <br /><br />I went through hundreds of charts of individual stocks this weekend, and the vast majority were short-side setups. They had broken down in mid-October and then bounced back to resistance levels on lighter volume. That is a pattern that you'd normally be looking to short, but in this market it hasn't worked at all. <br /><br />The main reason the market keeps producing these very vigorous recoveries is that there is just too much liquidity out there looking for a place to go. Once we start to bounce, the fear of being left behind drives market players to pile back in and scare the bears yet again. <br /><br />The great dilemma is that if you are using a disciplined approach based on charts, you never see good entry points for longs. We go directly from a technical breakdown and very poor action to straight-up action and a complete recovery. That is great if you are an unwavering bull, but it's very tricky if you are trying to use charts to navigate. <br /><br />The poor jobs report from Friday is being forgotten as the market focuses on some good economic news out of Germany and the G-20 economic news out of Scotland. Apparently the market likes the statement that countries have agreed to "continue to provide support for the economy until the recovery is assured." <br /><br />It is always difficult to trust strong opens on Monday mornings, but in this market environment, once we start running there is no looking back. If the bears are going to do something, they need a strong reversal here -- otherwise, it's looking like predictions that we have seen the highs of the year will be proved wrong yet again. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: DISH +6.0%, FUQI +5.4%, TTI +4.5% (light volume), ASX +2.1% (light volume), VE +2.0%, MCD +1.0%... Select financial names showing strength: RBS +3.8%, AIG +3.2%, ING +3.1%, CS +2.7%, BCS +2.7%, DB +2.5%, UBS +2.3%, C +1.7%, GS +1.3% (Treasury blocks the sale of tax credits by Fannie - WSJ)... Select metals/mining related names seeing early strength: RTP +5.5%, GFI +4.5%, BBL +4.4%, MT +4.3%, SLW +4.1%, BHP +3.9%, HMY +2.9%, GG +2.2%, VALE +2.2%, ABX +2.1%... Select oil/gas names trading higher: STO +2.9%, E +2.5%, BP +2.4%, PTR +2.3%, RDS.B +2.2%, RIG +2.1%, PBR +2.0%, RDS.A +1.9%, SLB +1.7%... Other news: EWBC +19.3% (has acquired the banking operations of United Commercial Bank; upgraded to Hold from Sell at Sandler O'Neill), CGEN +18.5% (announces discovery of genetic biomarker for predisposition to Type 2 Diabetes), ARIA +10.6% (still checking), SAY +8.8% (still checking), RSH +8.1% (will introduce Apple's iPhone 3G and iPhone 3GS in a limited number of company-owned stores; upgraded to Outperform at Credit Suisse), FSLR +2.0% (Balancing energy needs and material hazards - NY Times), MO +1.7% (Altria has a lush dividend and a best-selling product; now just needs a plan to get investors back on board -- Barron's), SHW +1.3% (Look for Sherwin-Williams to paint the town red once the economic recovery kicks into high gear -- Barron's)... Analyst comments: ARIA +10.6% ( upgraded to Overweight from Neutral at JP Morgan), ANF +6.3% (upgraded to Outperform at Credit Suisse), ADBE +3.3% (upgraded to Buy from Neutral at Goldman- DJ), BX +2.1% (upgraded to Outperform from Market Perform at Keefe Bruyette), MRK +1.7% (light volume; upgraded to Outperform at Leerink Swann), AZN +1.7% (upgraded to Buy from Hold at RBS). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: CHDX -22.9%, ENG -12.3%, HOGS -8.3%, SRZ -7.2% (light volume), ENER -3.4%... Select managed care related names showing weakness: WLP -2.0%, HUM -1.7%, UNH -1.4%, AET -1.0%... Other news: KCAP -9.4% (delays filing of third quarter report on form 10-Q), XNPT -5.7% (Xenoport and GlaxoSmithKline announced that the FDA has extended the original PDUFA goal date), NAT -4.8% (agreed to acquire its eighteenth vessel, a double-hull suezmax tanker built in a first class Far Eastern shipyard in 2002 for a purchase price of $51.5 million)... Analyst comments: VRSN -2.8% (cut to Sell at Goldman- Reuters), RIMM -0.9% (downgraded to Neutral from Positive at Susquehanna Financial).